Thalamic Dysconnectivity Seen in Those at Risk for Psychosis

This article originally appeared here.
Share this content:
Thalamic Dysconnectivity Seen in Those at Risk for Psychosis
Thalamic Dysconnectivity Seen in Those at Risk for Psychosis

WEDNESDAY, Aug. 12, 2015 (HealthDay News) -- Among individuals at clinical high risk for psychosis, thalamic dysconnectivity is evident, according to a study published online Aug. 12 in JAMA Psychiatry.

In a multicenter, two-year follow-up case-control study, Alan Anticevic, Ph.D., from the Yale University School of Medicine in New Haven, Conn., and colleagues examined whether thalamocortical connectivity is altered in individuals at risk for psychosis. Data were included for 243 individuals at clinical high risk of psychosis, of whom 21 converted to full-blown illness, and 154 healthy controls (all aged 12 to 35 years).

The researchers identified thalamocortical dysconnectivity among individuals at clinical high risk for psychosis, which was particularly pronounced in the participants who converted to full-blown illness. Widespread hypoconnectivity was seen between the thalamus and prefrontal and cerebellar areas; the pattern was more prominent among those who converted to full-blown illness. Marked thalamic hyperconnectivity was seen in sensory motor areas, which was also most pronounced among those who converted to full-blown illness. Significant correlations were seen for both patterns with concurrent prodromal symptom severity.

"Dysconnectivity correlated with symptom severity, supporting the idea that thalamic connectivity may have prognostic implications for risk of conversion to full-blown illness," the authors write.

Abstract
Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »